A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar, Stephen Stahl, Hans Jurgen Moller, Pierre Blier, David Kupfer, Shigeto Yamawaki, Hiroyuki Uchida, Michael Spedding, Guy M. Goodwin, David Nutt

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

Original languageEnglish
Pages (from-to)2318-2325
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume25
Issue number12
DOIs
Publication statusPublished - 2015 Dec 1

Fingerprint

Neurosciences
Terminology
Pharmacology
Psychotropic Drugs
Pharmaceutical Preparations

Keywords

  • Adherence
  • Mode of action
  • Neuroscience
  • Nomenclature
  • Pharmacological domain
  • Psychotropic drugs

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Pharmacology (medical)
  • Biological Psychiatry
  • Neurology
  • Pharmacology

Cite this

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. / Zohar, Joseph; Stahl, Stephen; Moller, Hans Jurgen; Blier, Pierre; Kupfer, David; Yamawaki, Shigeto; Uchida, Hiroyuki; Spedding, Michael; Goodwin, Guy M.; Nutt, David.

In: European Neuropsychopharmacology, Vol. 25, No. 12, 01.12.2015, p. 2318-2325.

Research output: Contribution to journalArticle

Zohar, J, Stahl, S, Moller, HJ, Blier, P, Kupfer, D, Yamawaki, S, Uchida, H, Spedding, M, Goodwin, GM & Nutt, D 2015, 'A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature', European Neuropsychopharmacology, vol. 25, no. 12, pp. 2318-2325. https://doi.org/10.1016/j.euroneuro.2015.08.019
Zohar, Joseph ; Stahl, Stephen ; Moller, Hans Jurgen ; Blier, Pierre ; Kupfer, David ; Yamawaki, Shigeto ; Uchida, Hiroyuki ; Spedding, Michael ; Goodwin, Guy M. ; Nutt, David. / A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. In: European Neuropsychopharmacology. 2015 ; Vol. 25, No. 12. pp. 2318-2325.
@article{d713102f95d94c14bf27270d387e4f2b,
title = "A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature",
abstract = "Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.",
keywords = "Adherence, Mode of action, Neuroscience, Nomenclature, Pharmacological domain, Psychotropic drugs",
author = "Joseph Zohar and Stephen Stahl and Moller, {Hans Jurgen} and Pierre Blier and David Kupfer and Shigeto Yamawaki and Hiroyuki Uchida and Michael Spedding and Goodwin, {Guy M.} and David Nutt",
year = "2015",
month = "12",
day = "1",
doi = "10.1016/j.euroneuro.2015.08.019",
language = "English",
volume = "25",
pages = "2318--2325",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

AU - Zohar, Joseph

AU - Stahl, Stephen

AU - Moller, Hans Jurgen

AU - Blier, Pierre

AU - Kupfer, David

AU - Yamawaki, Shigeto

AU - Uchida, Hiroyuki

AU - Spedding, Michael

AU - Goodwin, Guy M.

AU - Nutt, David

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

AB - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

KW - Adherence

KW - Mode of action

KW - Neuroscience

KW - Nomenclature

KW - Pharmacological domain

KW - Psychotropic drugs

UR - http://www.scopus.com/inward/record.url?scp=84959851997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959851997&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2015.08.019

DO - 10.1016/j.euroneuro.2015.08.019

M3 - Article

VL - 25

SP - 2318

EP - 2325

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 12

ER -